News
The Medicines and Healthcare products Regulatory Agency (MHRA) has put out a survey to gauge health institutions’ views on ...
JenaValve is obtaining FDA approval for the first transcatheter aortic valve designed to address aortic regurgitation.
The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera’s ArteraAI Prostate software.
The US Food and Drug Administration recently published an alert regarding Boston Scientific’s Watchman product, a heart ...
Reprieve Cardiovascular has closed an oversubscribed Series B financing round, raising $61m, for the trial of the Reprieve ...
Thermo Fisher Scientific is to integrate Syncell's Microscoop Mint technology into its Orbitrap Astral mass spectrometer.
Conformal has completed a Series D extension financing round, securing $32m to support its clinical trial of the CLAAS ...
Vicarious Surgical has delayed the clinical timeline for its surgical robot, having previously stated it would initiate first ...
The US FDA has granted approval to Nyxoah’s Genio system for treating individuals with moderate to severe obstructive sleep ...
Drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity ...
Patient demonstrations, ongoing clinical trials and heavy investment signal that BCIs could be commercialised by 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results